Sign In
Buy SYK
$335.96
-5.24 (-1.54%)
At Close: Aug 04, 2026
Strong Segmental Performance to Drive Stryker's Q4 Earnings?
01:35pm, Monday, 27'th Jan 2025
SYK's fourth-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
Stryker: A Cool Name For An Awesome Company, But Is It A Buy Ahead Of Earnings?
12:49pm, Monday, 27'th Jan 2025
Stryker Corporation is a high-quality, innovative medical device company with a strong history of revenue, earnings, and FCF growth, driven by R&D and M&A strategies. Shares are currently expensive wi
PAHC vs. SYK: Which Stock Should Value Investors Buy Now?
12:41pm, Friday, 24'th Jan 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with th
Stryker (SYK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:21am, Thursday, 23'rd Jan 2025
Beyond analysts' top -and-bottom-line estimates for Stryker (SYK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
04:20pm, Friday, 17'th Jan 2025
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purc
PAHC or SYK: Which Is the Better Value Stock Right Now?
12:55pm, Wednesday, 08'th Jan 2025
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value opportu
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inari Medica
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical
12:57pm, Tuesday, 07'th Jan 2025
SYK inks an agreement to acquire Inari Medical at a valuation of approximately $4.9 billion.
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
08:31am, Tuesday, 07'th Jan 2025
Inari Medical (NARI) stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker (SYK) proved to be true.
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
07:55am, Tuesday, 07'th Jan 2025
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal
04:48pm, Monday, 06'th Jan 2025
Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news.
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the
Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say
03:19pm, Monday, 06'th Jan 2025
Medical-device maker Stryker is in advanced talks to acquire Inari Medical , which makes devices that treat patients with venous diseases, people familiar with the matter told Reuters on Monday.
3 Stocks Helping Bring AI to Healthcare
09:43am, Tuesday, 31'st Dec 2024
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
5 MedTech Stocks That Are Poised to Beat the Market in 2025
10:01am, Monday, 30'th Dec 2024
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices.
